Dr. Anjana Rani Nair, BAMS., Dip (Pharm. Mgmt) MS (Clin Res) is a medical professional  with extensive theoretical and practical experience in the use of the Cytotron® CELLFORN® and Haemoseis-256, under the direct guidance of Dr. Rajah Vijay Kumar, the inventor and IP holder of the RFQMR platform technology and QMRT therapeutic modality. She is one of the very few highly trained individuals in the use of this device in multiple disease indications like oncology, musculo-skeletal and neurodegenerative diseases like MS. disc herniation and spinal dysplasia, Cancer drug delivery with FORN and related protocols. She has helped treat and manage more than 350 patients in the earliest clinical studies in these indications for CE certification and the FDA-related retrospective safety and efficacy study. She has been involved in a commercial Cytotron clinical setting involved with the  administration of Cytotron and management of Cancer an OA patients at the Ojus Anytime Medicare Services, in Bengaluru India, under the guidance of the late Dr. G.S. Nayar. She was the lead on the advanced training, testing and certification of senior clinicians and radiologists, as well as radiology technicians and nurses at the 2 study locations in Mexico City in 2019. Together with Dr. Kumar and Prof. Augustus, Dr. Nair has helped consolidate clinical data from several on-going studies being prepared for publication, including  preliminary data on the use of the Cytotron in Pediatric and Adult brain tumors, that will be used for the Humanitarian Use Designation for the pediatric brain tumor indication in the US.

She is a dedicated healthcare professional, contributing her unique skills,  professional competence and medical knowledge through  her continued desire to learn.